InsiderClue
Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
2,114
$138.79
$293.39K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
6,034
$137.63
$830.47K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
7,052
$136.83
$964.95K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
3,400
$135.44
$460.51K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
1,000
$134.38
$134.38K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
400
$133.12
$53.25K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
521
$95.00
$49.50K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
1,800
$93.92
$169.05K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
1,779
$92.26
$164.14K
Aaron Freidin
27 Aug 2026
Chief Financial Officer
Sold on a plan
7,900
$85.01
$671.58K
Joshua J. Ofman
27 Aug 2026
Chief Executive Officer
Sold on a plan
5,000
$85.02
$425.10K
Show all 48 transactions →

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 8
Sales at will 29
Transactions with no price 0
Shares from compensation/vesting 227,821
History held since 24 Jun 2024